Figure 3
From: Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients
(A) Significant difference was observed in the serum galectin-3 levels in surviving and deceased HD patients (p < 0.001). (B) Kaplan–Meier survival analysis for mortality in the two groups by serum galectin-3 level of 37.0 ng/mL. Patients with galectin-3 ≥ 37.0 ng/mL had significantly higher mortality rates than those with lower levels.
